Sarcoma: open trials in South Korea

17 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Seoul National University Hospital-Pediatrics ( Site 1972), Seoul · Asan Medical Center-Pediatrics - Pedicatric Oncology ( Site 1973), Seoul
Registry updated 2026-10-30
NCT06345729
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
The Catholic University of Korea, Incheon St. Mary's Hospital ( Site 3606), Bupyeong-gu · Keimyung University Dongsan Hospital ( Site 3611), Daegu · Yeungnam University Hospital ( Site 3607), Daegu · Chonnam National University Hwasun Hospital-Pulmonology ( Site 3604), Hwasun · Inha University Hospital ( Site 3610), Incheon · Chungnam national university hospital ( Site 3602), Junggu · Korea University Guro Hospital ( Site 3601), Seoul · Korea University Anam Hospital ( Site 3609), Seoul · Kyung Hee University Hospital ( Site 3605), Seoul · The Catholic University of Korea, Eunpyeong St. Mary's Hospital ( Site 3608), Seoul · The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 3600), Suwon · Pusan National University Yangsan Hospital-Lung Cancer Clinic ( Site 3603), Yangsan
Registry updated 2026-10-26
NCT07878364
Treatment Patterns and Survival Outcomes in High-Grade Osteosarcoma: A Multicenter Retrospective Study
Research · MedPacto, Inc.
National Cancer Center, Goyang-si · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul · Korea Cancer Center Hospital, Seoul
Registry updated 2026-10-16
NCT07541170
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Pusan National University Hospital, Busan · Yeungnam University Medical Center, Daegu · Chungnam National University Hospital, Daejeon · Ajou University Medical Center, Gyeonggi-do · Gachon University Gil Medical Center, Incheon · Chonnam National University Hwasun Hospital, Jeollanam-do · Seoul National University Bundang Hospital, Seongnam-si · Asan Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-10-13
NCT05588648
Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma
Trial Treatment · Phase 1/2 · MedPacto, Inc.
Seoul National University Bundang Hospital, Gyeonggi-do · National Cancer Center, Gyeonggi-do · Korea Institute of Radiological & Medical Sciences, Seoul · Samsung Medical Center, Seoul · Seoul ASAN Medical Center, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-07
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
Seoul National University Hospital | Oncology, Jongno -Gu · Asan Medical Center - Oncology, Seoul · Severance Hospital | Oncology, Seoul · Samsung Medical Center | Oncology, Seoul
Registry updated 2026-10-02
NCT04094610
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.
Asan Medical Center, Seoul · Local Institution - 6304, Seoul · Local Institution - 6303, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-09-25
NCT06644755
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1 · Daiichi Sankyo
Seoul National University Hospital, Seoul
Registry updated 2026-09-04
NCT07252739
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Severance Hospital, Yonsei University Health System ( Site 0080), Seoul
Registry updated 2026-09-02
NCT05646316
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Trial Treatment · Phase 3 · NRG Oncology
Gachon University Gil Hospital, Incheon · Samsung Changwon Hospital, Seoul · Ewha Woman's University Mokdong Hospital, Seoul · Gangnam Severance Hospital, Seoul · Asan Medical Center, Seoul
Registry updated 2026-08-07
NCT03093116
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.
Local Institution - 6306, Cheongju-si · Chonnam National University Hwasun Hospital, Hwasun-eup, Hwasun-gun · Asan Medical Center, Seoul · Samsung Medical Center, Seoul · Local Institution - 6307, Seoul · Seoul National University Hospital, Seoul · Local Institution - 6304, Seoul · Local Institution - 3001, Seoul · Local Institution - 3002, Seoul · Yonsei University Health System, Severance Hospital, Seoul · Local Institution - 3003, Seoul
Registry updated 2026-05-27
NCT04605770
Pemetrexed, Cisplatin With Soft Tissue Sarcoma
Trial Treatment · Phase 2 · Yonsei University
Severance hospital, Seoul
Registry updated 2026-04-30
NCT07250334
Prospective Phase I/II Study Evaluating the Safety and Efficacy of Preoperative Carbon Ion Radiotherapy in Patients With Soft Tissue Sarcoma : The SARCOMA-01 Trial by the Severance sARCOma Multidisciplinary Team
Trial Treatment · Yonsei University
Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul
Registry updated 2025-11-26
NCT05679921
Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma
Trial Treatment · Phase 2 · Yonsei University
Severance hospital, Seoul
Registry updated 2025-07-16
NCT05824975
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Trial Treatment · Phase 1/2 · GI Innovation, Inc.
Seoul National University Hospital, Seoul · Yonsei University Health System, Severance Hospital, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul · St. Vincent's Hospital, Suwon
Registry updated 2024-11-25
NCT05590572
A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma
Trial Treatment · Phase 1/2 · Second Affiliated Hospital, Zhejiang University, School of Medicine
Department of Orthopedic Surgery Chonnam National University, Donggu
Registry updated 2022-10-21
NCT03838718
REtroperitoneal SArcoma Registry: an International Prospective Initiative
Research · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Samsung Medical Center, Seoul
Registry updated 2019-02-12

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error